(Q37903139)

25 August 2017

1 reference

title

Overview of preoperative radiochemotherapy in breast cancer: past or future? (English)

1 reference

25 August 2017

0 references

Céline Bourgier

1

1 reference

25 August 2017

Felipe A Calvo

series ordinal

2

1 reference

25 August 2017

Hugo Marsiglia

series ordinal

3

1 reference

25 August 2017

Miguel Martín

series ordinal

4

1 reference

25 August 2017

publication date

1 July 2011

1 reference

Clinical and Translational Oncology

25 August 2017

published in

1 reference

25 August 2017

volume

13

1 reference

25 August 2017

issue

7

1 reference

25 August 2017

page(s)

446-450

1 reference

Comprehensive management of locally advanced breast cancer

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Ten-year outcome after combined modality therapy for inflammatory breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: results of a phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Neoadjuvant concurrent paclitaxel and radiation in stage II/III breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Locoregional treatment outcomes after multimodality management of inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

The use of chemoradiotherapy in oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Chemoradiotherapy for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Comparative study of the radiosensitizing and cell cycle effects of vinflunine and vinorelbine, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-Fluorouracil or ftorafur and X rays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Radiosensitizing nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Radiation response modification following molecular inhibition of epidermal growth factor receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Lapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Low doses of ionizing radiation promote tumor growth and metastasis by enhancing angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Evaluation of acute locoregional toxicity in patients with breast cancer treated with adjuvant radiotherapy in combination with bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-011-0681-2

Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer

21 January 2018

1 reference

12 December 2020

Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis

1 reference

12 December 2020

Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial

1 reference

12 December 2020

Mechanism of inhibition of cell proliferation by Vinca alkaloids.

1 reference

12 December 2020

Radiosensitization of chemotherapy-refractory, locally advanced or locally recurrent breast cancer with trastuzumab: a phase II trial

1 reference

12 December 2020

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute

1 reference

12 December 2020

Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications

1 reference

12 December 2020

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS)

1 reference

12 December 2020

Management of locally advanced breast cancer (stage III): a review.

1 reference

12 December 2020

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

12 December 2020

Concurrent paclitaxel and radiation therapy for breast cancer.

1 reference

12 December 2020

Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy

1 reference

12 December 2020

Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial

1 reference

12 December 2020

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

1 reference

12 December 2020

Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy

1 reference

12 December 2020

Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.

1 reference

12 December 2020

Sensitization of breast cancer cells to radiation by trastuzumab

1 reference

12 December 2020

Multimodal treatment for inflammatory breast cancer

1 reference

12 December 2020

Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.

1 reference

12 December 2020

Progressive inflammatory breast cancer in patient receiving chemotherapy: the importance of radiotherapy as a part of locoregional treatment

1 reference

12 December 2020

A phase II study of second-line neoadjuvant chemotherapy with capecitabine and radiation therapy for anthracycline-resistant locally advanced breast cancer

1 reference

12 December 2020

Ten-year results utilizing chemotherapy as primary treatment in nonmetastatic, rapidly progressing breast cancer

1 reference

12 December 2020

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

12 December 2020

Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation

1 reference

12 December 2020

The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 selectively potentiates radiation response of human tumors in nude mice, with a marked improvement in therapeutic index.

1 reference

12 December 2020

Locally advanced adenocarcinoma of the breast without distant metastasis treated with multimodal therapies

1 reference

12 December 2020

Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).

1 reference

12 December 2020

Fluorouracil: biochemistry and pharmacology

1 reference

12 December 2020

Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer

1 reference

12 December 2020

Thoracic radiotherapy and daily vinorelbine as radiosensitizer in locally advanced non small cell lung cancer: a phase I study

1 reference

12 December 2020

10.1007/S12094-011-0681-2

Identifiers

DOI

1 reference

25 August 2017

1 reference